ATAI vs PTC · rev $4.1M vs P/E 48, rev $2.74B
ATAI Life Sciences BV (ATAI) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
ATAI currently screens at market cap $555.8M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the ATAI and PTC stock pages for the full models.
Not investment advice.